NEW YORK, June 18, 2015 /PRNewswire/ -- OTC Markets
Group Inc. (OTCQX: OTCM), operator of Open, Transparent and
Connected financial marketplaces for 10,000 U.S. and global
securities, congratulates Cynapsus Therapeutics Inc. on its NASDAQ
listing. Cynapsus, a Toronto-based specialty pharmaceutical
company, was previously cross-traded on the OTCQX® Best Marketplace
in the U.S.
Since it joined OTCQX on July 18,
2013, Cynapsus' share price has risen 124% and its global
average daily dollar volume has increased substantially.
"We are thrilled with Cynapsus' success on OTCQX and are pleased
to congratulate the company and its management on its offering and
NASDAQ listing," said Jason
Paltrowitz, Executive Vice President – Corporate Services at
OTC Markets Group. "Our OTCQX and OTCQB premium marketplaces
provide convenient U.S. secondary trading markets for Canadian
companies like Cynapsus to connect with more investors and grow
their businesses. We wish the company continued success as it
takes this next step in its evolution."
"OTCQX helped us expand our investor base and increase our
average daily trading volume, which was instrumental in enabling us
to qualify for a NASDAQ Global listing," said Anthony Giovinazzo, CEO, President and Director
of Cynapsus Therapeutics.
OTC Markets Group is the global leader in exchange graduates,
advancing 83 companies to the New York Stock Exchange, NASDAQ and
NYSE MKT in 2014. More than 400 additional companies have
graduated from OTC Markets Group's marketplaces in the past four
years.
About OTC Markets Group Inc.
OTC Markets Group Inc.
(OTCQX: OTCM) operates Open, Transparent and Connected financial
marketplaces for 10,000 U.S. and global securities. Through
our OTC Link® ATS, we directly link a diverse network of
broker-dealers that provide liquidity and execution services for a
wide spectrum of securities. We organize these securities
into marketplaces to inform investors of opportunities and risks:
the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and
the OTC Pink® Open Marketplace. Our data-driven platform
enables investors to easily trade through the broker of their
choice at the best possible price and empowers a broad range of
companies to improve the quality and availability of information
for their investors. To learn more about how we create better
informed and more efficient financial marketplaces, visit
www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia
Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428,
saskia@otcmarkets.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/otc-markets-group-congratulates-cynapsus-therapeutics-on-nasdaq-listing-300101673.html
SOURCE OTC Markets Group Inc.